Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
Saved in:
| Title: | Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma. |
|---|---|
| Authors: | Liu Z; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Rao M; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Poiret T; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden., Nava S; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Meng Q; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., von Landenberg A; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Bartek J Jr; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience and Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Xie S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Sinclair G; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Peredo I; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Dodoo E; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Maeurer M; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden. |
| Source: | Oncotarget [Oncotarget] 2017 Aug 16; Vol. 8 (46), pp. 80208-80222. Date of Electronic Publication: 2017 Aug 16 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
